Latest News
-
Another multinational pharmaceutical company partners with Arrayjet
- Posted: 20/12/18
Read more...Arrayjet is pleased to announce the sale of a Marathon Argus to a FTSE 100 company involved in pharmaceutical drug and vaccine development. Enclosed within the JetMosphere Max, the instrument is capable of printing microarrays at ultra low temperatures. The Iris Optical QC System consists of twin cameras that sit either side of the print head, capturing images and evaluating quality of the printed arrays in real-time.
-
Prof. Faith Osier from KEMRI Wellcome Trust invited to Ted Talk for protein microarray work
- Posted: 06/04/18
Read more...Prof. Faith Osier from KEMRI - Wellcome Trust is invited by TED to talk about how Arrayjet technology is aiding her search for the "Holy Grail": a vaccine that could finally eradicate malaria.
-
A new microarray printer for the Department of Plant and Environmental Sciences at University of Copenhagen
- Posted: 22/03/18
Read more...The Section for Plant Glycobiology will be using their Marathon Argus to investigate plant cell wall polysaccharides, structure, synthesis, and degradation.
Arrayjet have a long-running relationship with the University of Copenhagen and are pleased to report this new installation.
-
Arrayjet are proud to welcome Dr. Joe Keegan, a globally renowned life science entrepreneur to join as non-executive director
- Posted: 03/08/17
Read more...We take great pride in announcing a game-changing addition of a new non-executive director, Dr Joseph Keegan to join our team. We are delighted to welcome Dr Joe Keegan, a San Francisco-based biotechnology entrepreneur and one of the most respected leaders in the life sciences industry, as our non-executive director to help drive forward future opportunities and make a transformative impact for the business.